IRCT2015052322383N1已完成4 期
A randomized double blind placebo-controlled trial: comparison of azithromycin with doxycycline prophylaxis against leptospirosis in human in an endemic area
Vice Chancellor for Research, Mazandaran University of Medical Sciences0 个研究点目标入组 270 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 4 期
- 状态
- 已完成
- 发起方
- 入组人数
- 270
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 years 至 no limit(—)
- 性别
- All
入选标准
- •Inclusion criteria
- •All persons residing in endemic area of this disease and will supposed to work in the paddy field after taking a verified consent; All persons in the range of 18- 65 years old; Negative screening test for leptospirosis ; Agree to apply the doxycycline / azithromycin / placebo for all the times of paddy work ; Willing to regular monitoring for clinical manifestation; Willing to regular monitoring for three intermittent screening testing; Agree to report daily water contact; Agree to consult the related physician prior to taking any medication; No history of allergies to azithromycin or related compounds; No history of allergies to doxycycline or related compounds
- •Exclusion criteria:All persons who have positive first screening test for leptospirosis ;When the persons have hypersensitivity to azithromycin and doxycycline in history ; Pregnant women for doxycycline group; Severe adverse reaction for example; severe photosensitivity due to doxycycline;Severe adverse reaction to azithromycin;All persons who don’t agree to enroll in the research;All persons who don’t agree consent form
排除标准
- 未提供
研究者
相似试验
已完成
4 期
Study of controlled release mebeverine in irritable bowel syndrome in comparison to placebo.CTRI/2018/03/012897Department of Pharmacology40
已完成
不适用
A study to assess the effects of GutGard in the management of Helicobacter pyloriCTRI/2011/08/001968ICS CO LTD100
已完成
不适用
A comparative clinical trial to study the effect of Herbal Supplements- NRCC-01 & NRCC-02 in pre-diabetic subjects.CTRI/2011/05/001729atural Remedies Pvt Ltd150
进行中(未招募)
1 期
A randomized double blind placebo controlled trial of Memantine in the treatment of Agitation in Alzheimers Dementia - MAGD trail (Memantine for Agitation in Dementia)Alzheimers dementiaEUCTR2005-005087-93-GBEast Kent Hospitals NHS Trust164
进行中(未招募)
不适用
A randomized double blind placebo controlled trial of intranasal submucosal bevacizumab in hereditary hemorrhagic telangiectasia - Bevazizumab in HHTepistaxisEUCTR2009-018049-19-ATMedizinische Universität Wien,Univ.Klinik f.Hals-, Nasen- und Ohrenkrankheiten30
